ReviewMicroorganisms2026
An Overview of Bioproducts from Wastewater-Grown Microalgae: Recent Advancements, Economic and Feasibility Concerns.
Review in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Global wastewater generated in unprecedented volumes places a significant strain on aquatic environments, challenging the municipal sector to transition from energy-heavy pollutant removal technologies towards alternative resource recovery strategies with a low carbon footprint. The aim of this work is to review microalgae-based phycoremediation as a sustainable, cost-effective alternative that extracts nutrients from municipal, agricultural, and industrial streams without generating secondary chemical pollution. By utilizing these nutrient-rich effluents, microalgal cultivation generates valuable biomass for downstream valorization into biofuels, biofertilizers, biostimulants, and high-value biopolymers, while eliminating or reducing the costs of synthetic cultivation mediums. However, integrated techno-economic analyses (TEA) and life cycle assessments (LCA) reveal critical socio-technical bottlenecks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.